Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

People / Peter Parker

Peter Parker

PrincipalPrincipalMission BiocapitalMA
Roles
1 current, 1 past
Investments attributed to this person
0
No investment attributed yet. Attribution needs a source naming this person on the deal: a quote, a board seat, a portfolio page credit.
Board seats and vehicles
0 boards, 0 vehicles
None on record.
Timeline
2
  1. May 18, 2022
    Peter Parker (Managing Member Of Mission Biocapital V, Gp Llc) no longer on Schedule A of Mission Biocapital
    Person left Inference SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Apr 1, 2020
    Peter Parker joined Schedule A of Mission Biocapital as Managing Member Of Mission Biocapital V, Gp Llc
    Person joined Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)